PROGRAMME - uhts.org.rs · Professor Aleksandar Lucic President DLTH Meeting 2009 Welcome Message....

PROG

RAM

ME

2

Organized by:

Serbian Society of Haemostasis and ThrombosisPresident: Danijela Mikovic Secretary General: Ljiljana Rakic

Danubian League against Thrombosis and Haemorrhagic DisordersPresident: Günter VogelSecretary General: Helmut Sinzinger

Blood Transfusion Institute of Serbia, Svetog Save 39, 11000 Belgrade • Phone: +381 11 2455 838 • Fax: +381 11 2458 328

Committees 4Welcome Message 5Programme Overview 7Scientifi c Programme - Oral Sessions 9Scientifi c Programme - Poster Session 19Map of the Meeting Rooms 28General Information 29Sponsoring and Exhibition 35

4 Danubian League against Thrombosis and Haemorrhagic Disorders

Committees

MEETING PRESIDENTAleksandar Lucic

ORGANIZING COMMITTEEDanijela Mikovic, PresidentVisnja CanakZoran StanojkovicVesna Subota

SCIENTIFIC COMMITTEEIvo Elezovic, PresidentHelmut SinzingerEmilija StojimirovicRadmila BaklajaPredrag MiljicNebojsa Antonijevic

SECRETARIATLjiljana RakicBiljana VuckovicGordana AntuljeskovDarko Antic

15th International Meeting, Belgrade 2009 5

Dear colleagues and friends,

On behalf of the Organizing Committee and on my own I wish a most cordial welcome to all participants of the 15th Danubian League Meeting against Thrombosis and Haemorrhagic Disorders, taking place from May 14 to 16, 2009 in Belgrade, capital of the Republic of Serbia.

By its primordial energy, the almighty Danube brings closer and unites people of various nationalities, religions, languages and cultural heritage. Almost thirty years ago Danube was the originator of the visionary professor Helmut Vinazzer’s idea of creating the Danubean League against Thrombosis and Haemorrhagic Disorders. Based on the Danubian affi liation, the Danubian League, in all its creative enthusiasm, gathers the experts of various medical and biological specialties, whose fundamental fi eld of interest resides within thrombosis and haemorrhagic syndromes.

It is our mutual wish to make the forthcoming meeting in Belgrade a strong stimulus for the improvement of traditional, professional and scientifi c regional cooperation.

Waiting for you openheartedly, wishing to make all three Belgrade Danubian League Meeting days memorable by the most up to date achievements in domain of haemostasis disorders research and by the friendly social activities, I address you once more with a most sincere and warm invitation to the next Danubian League Meeting in Belgrade, famous by its cordial hospitality.

Sincerely Yours,

Professor Aleksandar LucicPresident

DLTH Meeting 2009

Welcome Message


Programme Overview

Thursday, May 14

14:30 – 16:30 Session: Venous Thromboembolism: Risk Factors, Diagnosis and Therapy

17:00 – 18:00 Satellite Symposium: Bayer Health Care, Bayer Schering Pharma

18:00 – 19:00 Satellite Symposium: Siemens Healthcare Diagnostics and Interlab exim

19:00 – 19:45 Opening Ceremony

20:00 – 22:00 Welcome Reception

Friday, May 15

08:30 – 09:00 Plenary Lecture

09:00 – 10:50 Session: Current and Future Assays of Haemostasis


11:40 – 13:00 Session: Periodontal Disease and Haemostasis

Session: Pediatric Haemostasis

13:00 – 14:00 Satellite Symposium: Novo Nordisk

14:00 – 15:00 Lunch sponsored by Novo Nordisk


15:00 – 16:50 Session: Principles of Haemophilia Care

16:50 – 17:15 Poster Session

17:15 – 17:30 Presentation: Instrumentation Laboratory

17:30 – 18:30 Satellite Symposium: Baxter

20:30 – 00:00 Gala Dinner sponsored by Baxter

Saturday, May 15

08:30 – 10:00 Visit to the Royal Palace

10:00 – 10:50 DLTH Assembly


11:40 – 13:00 Session: Women and Haemostasis Disorders

Session: Arterial Thrombosis: Risk Factors and Therapy

13:00 – 14:00 Satellite Symposium: Octapharma

14:00 – 15:00 Lunch sponsored by Octapharma

15:00 – 15:30 Closing Ceremony

Scie

ntifi

c Pr

ogra

mm

e –

Oral

Ses

sion

s


Abbreviations:

PL - Plenary LectureSOA - State of the ArtOP - Oral PresentationPP - Poster Presentation


Thursday, May 14, 2009 14:30-16:30 Room Atrium

VENOUS THROMBOEMBOLISM: RISK FACTORS, DIAGNOSIS AND THERAPYChairs: Alekandar Lucic, Sam Schulman, Ivo Elezovic

14:30 PL 1 THE OLD VERSUS THE NEW IN ANTICOAGULATION FOR VENOUS THROMBOEMBOLISMS. Schulman

15:00 SOA 2 OBSTACLES IN DIAGNOSTICS AND THERAPY OF HEPARIN-INDUCED THROMBOCYTOPENIAN. Antonijevic, N. Radovanovic, M. Kocica, D. Mikovic, M. Kovac, S. Tadic, I. Antonijevic, S. Draskovic, V. Djordjevic, B. Stojanovic, S. Obradovic, B. Calija, J. Perunicic, B. Terzic

15:20 OP 3 AN OVERVIEW OF GENETIC RISK FACTORS IN THROMBOPHILIAV. Djordjevic, Lj. Rakicevic, D. Radojkovic

15:30 OP 4 TAFI LEVELS AND Thr325Ile POLYMORPHISM INFLUENCE CLINICAL EXPRESSION OF THROMBOPHILIA IN CARRIERS OF FV LEIDEN OR FII 20210A MUTATIONS P. Miljic, E. Heylen, J. Willemse, V. Djordjevic, D. Radojkovic, M. Colovic, I. Elezovic, D. Hendriks

15:40 SOA 5 THROMBOSIS IN ANTIPHOSPHOLIPID SYNDROME: RESULTS FROM THE SERBIAN NATIONAL APS REGISTRYLj. Stojanovic, I. Elezovic, D. Marisavljevic, D. Petrovic, Z. Mikovic, R.Petrovic, R. Stojanovic, N. Damjanov, M. Mijailovic-Ivkovic, N. Milinic

16:00 OP 6 DIFFERENT D-DIMER TESTS COMPARING TO ULTRASOUND EXAMINATION OF DEEP VEIN THROMBOSIS D. Vasic, L. Davidovic, V. Dopsaj, M. Vranes, O. Radmili

16:10 OP 7 VALUE OF TRANSTHORACIC ECHOCARDIOGRAPHY IN THE DIAGNOSIS OF PULMONARY EMBOLISMD. Obradovic, U. Batranovic, B. Sevic, B. Zaric, J. Vucicevic-Trobok, B. Bogdanov

16:20 Discussion

16:30 - 17:00 Coffee break Business Centre

Thursday, May 14, 2009 17:00-19:45 Room Atrium

Thursday, May 14, 2009 20:00-22:00 Business Centre

17:00 Satellite Symposium Bayer Health Care, Bayer Schering Pharma

18:00 Satellite Symposium Siemens Healthcare Diagnostics and Interlab exim

19:00 Opening Ceremony

Welcome Reception


Friday, May 15, 2009 08:30-10:50 Room Atrium

CURRENT AND FUTURE ASSAYS OF HAEMOSTASISChairs: Igor Bokarev, Mojca Stegnar, Jovan Antovic

08:30 PL 32 HOW TO USE DIC DIAGNOSIS TODAY?I. N. Bokarev, L.V. Popova

09:00 SOA 33 FACTORS INFLUENCING FIBRIN STRUCTURE AND FUNCTION. RELEVANCE TO CLINICAL DISEASE A. Antovic, N.H. Wallen, F. Mobarrez, G. Jorneskog, S. He, M. Blomback

09:20 OP 34 THE ROLE OF ROTEM IN REAL TIME ASSESSMENT OF HEMOSTASIS IN SURGICAL SETTINGSD. Vucelic, P. Miljic

09:30 OP 35 ESTIMATION OF THROMBIN PRODUCTION IN DIFFERENT SUBJECTSM.P. Makris, P.E. Makris

09:40 SOA 36 HOW TO MEASURE PLATELET MICROPARTICLES USING FLOW-CYTOMETRY? F. Mobarrez, N. H. Wallen, N. Egberg, G. Jorneskog , M. Hansson, J. Antovic

10:00 OP 37 FLOW CYTOMETRIC AND FUNCTIONAL INVESTIGATIONS OF CRYOPRESERVED AND LIQUID STORED PLATELETSD. Vucetic, B. Balint, D. Vojvodic, S. Mandic-Radic, V. Subota, M. Trkuljic

10:10 SOA 38 PLATELET FUNCTION TESTS AND RESISTANCE TO ANTIPLATELET THERAPYM. Stegnar

10:30 OP 39 STUDY OF THE RESISTANCE TO ASPIRIN BY DETERMINATION OF GLYCOPROTEIN ON THE PLATELET MEMBRANEM. Moshou, M.P. Makris, G. Koliakos, P.E. Makris

10:40 Discussion

10:50-11:10 Coffee break Business Centre



PERIODONTAL DISEASE AND HAEMOSTASIS Chairs: Helmut Sinzinger, Andreas Eder, Milan Jurisic

11:10 PL 49 IS LIPOPROTEIN (a) REGULATING THE PROSTAGLANDIN I2-SYNTHESIS STIMULATING PLASMA FACTOR?H. Sinzinger, E. Ruppert, H. Laimer

11:40 OP 50 EFFECTS OF ENAMEL MATRIX DERIVATIVE (EMD) ON PROLIFERATION, MIGRATION AND ANGIOGENIC FACTOR EXPRESSION OF ENDOTHELIAL CELLS IN VITROK. Bertl, N. An, C. Bruckmann, M. Dard, O. Andrukhov, M. Matejka, X. Rausch-Fan

11:50 OP 51 INFLUENCE OF PERIODONTAL DISEASE ON CARDIOVASCULAR DISEASE PARAMETERSA. Eder, D.I. Ancutici

12:00 OP 52 (ISO-)EICOSANOID PRODUCTION PROFILE IN PERIAPICAL GRANULOMAS AND THEIR ROLE IN BONE DESTRUCTIONE. Kögl, A. Eder, H. Sinzinger

12:10 OP 53 (ISO-)PROSTANES - A MARKER FOR PARODONTOPATHY?C. Presenhuber, A. Eder, A. Nell, H. Sinzinger

12:20 OP 54 PLASMA BUT NOT SERUM THROMBOXANE B2 IS CORRELATED TO PERIODONTAL DISEASE INDICESH. Sinzinger, S. Marchesi, G. Lupattelli, A. Eder

12:30 OP 55 EFFECTS OF PORPHYROMONAS GINGIVALIS LIPOPOLYSACCHARIDE ON HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS WITH REGARD TO EXPRESSION OF CELL ADHESION MOLECULESI. Steiner, O. Andrukhov, S. Liu, M. Matejka, X. Rausch-Fan

12:40 Discussion


Friday, May 15, 2009 11:50-13:00 Room Beograd


PEDIATRIC HAEMOSTASIS Chairs: Emilija Stojimirovic, Nada Rasovic, Dejan Skoric

11:50 OP 56 TREATMENT OF INTRACRANIAL HAEMORRHAGE WITH RECOMBINANT FACTOR VIIa IN A PATIENT WITH APLASTIC ANEMIAD. Janic, N. Krstovski, L. Dokmanovic, P. Rodic

12:00 OP 57 KASABACH-MERRITT SYNDROME - ASSOCIATED KAPOSIFORM HEMANGIOENDOTHELIOMA: SUCCESSFULLY TREATED VASCULAR NEOPLASMA WITH CONSUMPTIVE COAGULOPATHYD. Aleksic, D. Djokic, R. Simic, S. Djuricic, D. Redzic, M. Jovic, A. Sarajlija

12:10 OP 58 KASABACH-MERITT SYNDROME: A STATE OF ALARMING CONSUMPTIVE COAGULOPATHY S. Sindjic-Antunovic, D. Skoric, M. Jesic, M. Lukac, D. Vujovic, Z. Krstic, S. Maglajlic

12:20 OP 59 COAGULATION DISTURBANCES IN PATIENTS WITH VENO-OCCLUSIVE DISEASE AFTER BONE MARROW TRANSPLANTATIOND. Jevtic, D. Vujic, Z. Zecevic, D. Veljkovic, S. Gazikalovic

12:30 OP 60 IMPORTANCE OF LIFELONG ORAL ANTICOAGULANT THERAPY IN ADOLESCENT WITH CONGENITAL THROMBOPHILLIAM. Jovic, D. Redzic, O. Serbic, D. Aleksic, D. Djokic

12:40 OP 61 INFLUENCE OF OBSTETRIC FACTORS ON QUALITY OF UMBILICAL CORD BLOOD UNITSD. Skoric, M. Sindjic, M. Saracevic

12:50 Discussion

Satellite Symposium Novo Nordisk

14:00-15:00 Lunch sponsored by Novo Nordisk Restaurant Exclusive



Friday, May 15, 2009 16:50-17:15 Room Forum



Friday, May 15, 2009 20:30 Kalemegdanska terasa

PRINCIPLES OF HAEMOPHILIA CARE Chairs: Christopher Ludlam, Danijela Mikovic, Radmila Baklaja

15:00 PL 69 HAEMOPHILIA CARE IN EUROPE – HOW CAN WE IMPROVE IT?C. Ludlam

15:30 OP 70 BUILDING THE REGISTRIES AND NETWORKS FOR HEMOPHILIA CARE. A NATIONAL APPROACH: SLOVAKIAA. Batorova, M. Zarnovicanova

15:40 OP 71 QUALITY OF HEMOPHILIA TREATMENT IN SERBIA: NATIONAL HAEMOPHILIA REGISTRY REPORTD. Mikovic, Lj. Rakic, G. Jankovic-Trsnjak, R. Baklaja

15:50 OP 72 CONTINUOUS FVIII REPLACEMENT FOR OPEN HEART SURGERY IN THE NEWBORN - A CASE REPORTM. Kuzmanovic, M. Stajevic, V. Vukomanovic, N. Rasovic, B. Jankovic,O. Serbic

16:00 OP 73 MOLECULAR GENETIC DIAGNOSTICS OF HEMOPHILIA A IN SLOVENE PATIENTSM. Debeljak, L. Kitanovski, M. Benedik-Dolnicar

16:10 OP 74 PROPHYLAXIS IN ADULTS WITH HAEMOPHILIA A: BENEFIT OR RISK?S. Zupancic-Salek

16:20 OP 76 ORTHOPAEDIC MANAGEMENT OF MUSCULOSCELETAL COMPLICATIONS OF HAEMOPHILIA PATIENTS IN HUNGARYL. Nemes, L. Bartha

16:30 OP 77 BENEFITS OF EARLY TREATMENT OF BLEEDINGIN HAEMOPHILIA PATIENTS WITH INHIBITORSP. Salaj

16:40 Discussion

Poster Session & Coffee Break

Presentation Instrumentation Laboratory

Satellite Symposium Baxter

Gala Dinner sponsored by Baxter


Saturday, May 16, 2009

Saturday, May 16, 2009 10:50-12:20 Room Atrium

08:30-10:00 Visit to the Royal Palace

10:00-10:50 DLTH Assembly Room Beograd

10:30-10:50 Coffee break Business Centre

WOMEN AND HAEMOSTASIS DISORDERS Chairs: Flora Peyvandi, Gorana Mitic, Predrag Miljic

10:50 PL 92 OBSTETRIC AND GYNECOLOGICAL PROBLEMS IN WOMEN WITH INHERITED BLEEDING DISORDERSF. Peyvandi

11:20 OP 93 MENORRHAGIA AND COAGULATION ABNORMALITIESS. Djukic, N. Andjelkovic, P. Djurdjevic, A. Djukic, J. Antovic

11:30 OP 94 EFFICACY AND SAFETY OF THE LOW MOLECULAR WEIGHT HEPARIN NADROPARIN AND UNFRACTIONATED HEPARIN FOR TREATMENT OF VENOUS THROMBOEMBOLISM DURING PREGNANCY AND PUERPERIUM G. Mitic, M. Kovac, Lj. Povazan, V. Djordjevic, Z. Magic, I. Salatic, R. Lazic, N. Antonijevic, A. Novakov-Mikic

11:40 OP 95 RECURRENT FETAL LOSSES: ETIOLOGICAL AND THERAPEUTIC APPROACH USING MAINLY THE INNOHEPA. Foifa, M.P. Makris, A. Kanidis, P.E. Makris

11:50 OP 96 CORRELATION BETWEEN THE LOW MOLECULAR WEIGHT HEPARIN DOSE AND THE PLASMA LEVELS OF ANTI Xa ACTIVITY IN PREGNANT WOMENM. Scekic, G. Mitic, Dj. Jurisic, Lj. Povazan, R. Tesic, M. Petkovic, B. Jakovljevic, Z. D. Jelicic

12:00 Discussion


Saturday, May 16, 2009 11:20-13:00 Room Beograd



ARTERIAL THROMBOSIS: RISK FACTORS AND THERAPYChairs: Günter Vogel, Graziana Lupattelli, Rajko Radovancevic

11:20 SOA 97 LIPOPROTEINS AND ATHEROGENESIS: AN UPDATE G. Lupattelli

11:40 OP 98 FIBRINOLYTIC DISORDERS AND Lp(a) LIPOPROTEIN IN ISCHEMIC STROKE PATIENTS B. Vuckovic, V. Canak, M. Djeric, S. Novaković-Anucin, S. Gnip, T. Ilic

11:50 SOA 99 THROMBOGENIC PROFILE OF LEUKOCYTES: CLINICAL AND EXPERIMENTAL EVIDENCESN. Maugeri

12:10 OP 100 EFFECT OF, UMBILICAL CORD, BLOOD CELLS IN THE “EXPRESSION” OF PLATELET GLYCOPROTEIN RECEPTORSM. Moshou, D. Vasileiadou, M.P. Makris, G. Koliakos, P.E. Makris

12:20 OP 101 EXTREMELY HIGH LEVELS OF PLATELET ACTIVATION MARKERS ASSOCIATED WITH CEREBROVASCULAR ACCIDENTR. Radovancevic, N. Matijevic, A. Bracey, I. Gregoric, O.H. Frazier

12:30 OP 102 HAEMOSTASIS PARAMETERS FOR THE PREDICTION OF ISCHEMIA DURING ADENOSINE-EXERCISE-SPECT STRESS TEST IN ASYMPTOMATIC CORONARY PATIENTS AFTER CORONARY STENTINGS. Obradovic, B. Baskot, V. Subota, D. Mikovic, N. Antonijevic, J. Antovic, N. Djenic, B. Gligic

12:40 OP 103 THE EFFECT OF THE ANTIAGGREGATIONAL THERAPY ON THE BYPASS LONG-TERM PATENCYD. Vasic, L. Davidovic, Z. Maksimovic, O. Radmili, M. Vranes

12:50 Discussion

Satellite Symposium Octapharma

14:00-15:00 Lunch sponsored by Octapharma Restaurant Exclusive

Closing Ceremony

Scie

ntifi

c Pr

ogra

mm

e –

Post

er S

essi

on


VENOUS THROMBOEMBOLISM: RISK FACTORS, DIAGNOSIS AND THERAPY

POSTER PRESENTATIONS

PP 8 NATIONAL REGISTRY OF THROMBOPHILIC STATES IN SLOVAK REPUBLICI. Plamenova, J. Chudej, K. Gregorova, L. Bartosova, M. Dobrotova, P. Chudy, J. Stasko, P. Kubisz

PP 9 PREVALENCE OF THROMBOPHILIC DEFECTS IN WOMEN WITH VENOUS THROMBOEMBOLISM IN PREGNANCY AND PUERPERIUM AND ITS CONNECTION WITH THROMBOSIS LOCALIZATION G. Mitic, M. Kovac, Lj. Povazan, V. Djordjevic, Z. Magic, I. Salatic, R. Lazic, N. Antonijevic, A. Novakov-Mikic

PP 10 HOMOCYSTEINEMIA LEVELS AND METHYLENTETRAHYDROFOLATE REDUCTASE C677T GENOTYPES IN PATIENTS WITH PULMONARY EMBOLISMN. Antonijevic, A.Beletic, D. Mirkovic, V. Sango, I. Novakovic, V. Djordjevic, S. Obradovic, J. Perunicic, G.Mitic, B. Jakovljevic, Z. Vasiljevic

PP 11 REVIEW OF PATIENT WITH THROMBOPHILIA ASSOCIATED WITH ESSENTIAL THROMBOCYTHAEMIAN. Govedarovic, D. Markovic, T. Vukicevic, M. Vucic

PP 12 MESO-ATRIAL SHUNT FOR MANAGEMENT OF FACTOR V LEIDEN RELATED BUDD-CHIARRI SYNDROME: CASE REPORTM. Veljovic, A. Popadic

PP 13 RECURRENT DEEP VENOUS THROMBOSES IN A PATIENT WITH FACTOR V LEIDEN AND MTHFR C677T MUTATIONS B. Teodorovic, Dj. Teodorovic, D. Kokar-Gusa, S. Martinovic-Poljak

PP 14 CONGENITAL-CYANOTIC HEART DISEASE AND HYPERCOAGULABILITY OF BLOOD - CASE REPORTO. Simonovic, L. Macukanovic-Golubovic, T. Vukicevic, D. Tasic

PP 15 POSTOPERATIVE DEEP VEIN THROMBOSIS AFTER LAPAROSCOPIC CHOLECYSTECTOMYZ. Stanojkovic, D. Milic

PP 16 THROMBOSIS OF THE INFERIOR VENA CAVA AND PULMONARY THROMBOEMBOLISMJ. Vucicevic-Trobok, B. Bogdanovic, S. Pekovic, M. Stojanovic, O. Obradovic

PP 17 PULMONARY EMBOLISM IN INTENSIVE CARE UNITN. Bogdanovic, M. Bojic, V. Celic, M. Dekleva, Dj. Lalosevic

PP 18 CORRELATION BETWEEN PAI-1 AND Lp(a) IN DEEP VENOUS THROMBOSISE. Todorovska, T. Makarovska-Bojadjieva, S. Kostovska

PP 19 FIBRINOLYSIS DISTURBANCE IN DEEP VENOUS THROMBOSISE. Todorovska, T. Makarovska-Bojadjieva, N. Dimoska



PP 20 THE USE OF D-DIMER WITH NEW THRESHOLD CAN BE USEFUL IN DIAGNOSIS OF VENOUS THROMBOEMBOLISM IN PREGNANCYM. Kovac, Z. Mikovic, Lj. Rakicevic, S. Srzentic, V. Mandic, O. Savic, V. Djordjevic, D. Radojkovic, I. Elezovic

PP 21 THE MANAGEMENT OF VENOUS THROMBOEMBOLISMI. Nikoloska, R. Apostolovska, V. Neceva, J. Angelovski, E. Velkova, T. Makarovska, D. Stambolieva, S. Atanasova

PP 22 THE USE OF THROMBOPROPHYLAXIS IN THE PATIENS WITH GENERAL AND GYNECOLOGIC SURGERYK. Lazarovski, V. Karamandi-Lazarovska, E. Todorovska, R. Dukovski

PP 23 ANTITHROMBOTIC THERAPY IN PATIENTS WITH MECHANICAL HEART VALVESV. Canak, Lj. Povazan, G. Mitic, S. Novakovic-Anucin, S. Gnip, B. Vuckovic, P. Filipov, M. Scekic

PP 24 ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION IN MACEDONIAR. Apostolovska, K. Dimitrovski, V. Dejanova, T. Balkanov, V. Neceva, S. Useini, I. Nikoloska

PP 25 HEMORRHAGIC AND THROMBOEMBOLIC COMPLICATIONS DURING ANTITHROMBOTIC PREVENTIVE THERAPY IN ATRIAL FIBRILLATIONS. Gnip, S. Novakovic-Anučin, V. Canak, Lj. Povazan, G. Mitic, B. Vuckovic, P. Filipov, M. Scekic

PP 26 FOLLOW UP OF ORAL ANTICOAGULANT THERAPYM. Paunovic, Lj. Suput-Tomas, B. Janković-Orescanin

PP 27 FOLLOW UP OF THE ORAL ANTICOAGULANT THERAPY – OUR EXPERIENCE Lj. Ilincic, B. Mihic-Tomic, S. Stojkovic, M. Bozovic, V. Djurovic

PP 28 HOW TO USE GENETIC INFORMATION DURING THE TREATMENT OF PATIENTS WITH ANTIVITAMINS KT. Kondratieva, I. N. Bokarev

PP 29 EFFICACY AND SAFETY OF UNFRACTIONATED AND LOW MOLECULAR WEIGHT HEPARIN USED AS PERIOPERATIVE BRIDGING THERAPY IN PATIENTS WITH MECHANICAL HEART VALVES G. Mitic, Lj. Povazan, S. Gnip, S. Novakovic-Anucin, M. Scekic

PP 30 BLEEDING CONTROL AFTER TEETH EXTRACTIONS IN PATIENTS ON ORAL ANTICOAGULANT TREATMENT WITHOUT THERAPY INTERRUPTIOND. Stojanovic, S. Colic, E. Krsljak, M. Jurisic

PP 31 HEPARIN-INDUCED THROMBOCYTOPENIA OCCURRED AFTER CARDIOSURGICAL TREATMENT OF ATRIAL MIXOMA: A CASE REPORTI. Djunic, D. Tomin, N. Antonijevic, M. Kovac, G. Jankovic, A. Vidovic, I. Elezovic


CURRENT AND FUTURE ASSAYS OF HAEMOSTASIS


PP 40 COMPARISON OF THREE METHODS FOR D-DIMER DETERMINATIONS. Jurkic, M. Perovic

PP 41 D-DIMER TEST APPLICATION IN THE HEALTH CARE CENTRE OF SOMBORE. Adjic-Tosegi

PP 42 HAEMOSTASIS SCREENING TESTS IN POTENTIAL PLATELET APHERESIS DONORS N. Vavic, D. Mikovic, Lj. Rakic, M. Sindjic, S. Draskovic, M. Kovac, A. Maslac, Z. Garic, V. Srejic

PP 43 MULTIPLATE®- BASED POINT-OF-CARE MANAGEMENT FOR DIAGNOSIS AND TREATMENT OF BLEEDING DURING HEART SURGERYB. Calija, M. Jovic, B. Djukanovic

PP 44 QUALITY CONTROL - DETERMINATION OF LOCALLY OWN REFERENCE RANGES USING MULTIPLATE®V. Libek, A. Kulic, A. Strugar, L. Mijovic-Nikolic, N. Rankovic

PP 45 STICKY PLATELET SYNDROME: ROLE OF FLOW CYTOMETRYP. Kubisz, L. Bartosova, J. Fedorova, J. Ivankova, P. Holly, J. Stasko

PP 46 PLATELET FUNCTION AND COAGULATION ABNORMALITIES IN TYPE 1 GAUCHER PATIENTM. Mitrovic-Vasiljevic, N. Suvajdzic, I. Elezovic, P. Miljic, Z. Sumarac, D. Janic, M. Djordjevic, M. Petakov, I. Djunić, P. Rodic

PP 47 THE USEFULNESS OF PFA-100 CLOSURE TIME AS SCREENING TEST FOR VON WILLEBRAND DISEASEL. Kitanovski, V. Rajic, A. Trampus, M. Benedik-Dolnicar

PP 48 IMPLEMENTATION OF THE SEMIQUANTITATIVE ANALYSIS OF VON WILLEBRAND FACTOR MULTIMERS USING SDS AGAROSE ELECTROPHORESIS METHODI. Jaglicic, O. Savic, D. Mikovic, M. Jovicic

PEDIATRIC HAEMOSTASIS

PP 62 LUPUS ANTICOAGULANT ANTIBODIES IN CHILDRENO. Serbic, M. Djuric, G. Vlahovic, D. Veljkovic, M. Kuzmanovic, D. Micic, S. Pasic, D. Jevtic

PP 63 HYPERCOAGULABILITY IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIAV. Bogicevic, G. Kostic, D. Jovancic, A. Kostic



PP 64 THROMBOTIC MICROANGIOPATHY INDUCED BY CMV AND HHV6 INFECTION AFTER ALLOGENEIC BONE MARROW TRANSPLANTATIONZ. Zecevic, D. Vujic, D. Jevtic, D. Veljkovic, O. Serbic

PP 65 COAGULATION TESTING OF NEWBORN WITH CEPHALHEMATOMAV. Libek , A. Kulic, L. Mijovic-Nikolic, A. Strugar, N. Rankovic, B. Kovacevic

PP 66 VITAMIN K DEFICIENCY BLEEDING IN A CHILD WITH CHOLESTASISN. Krstovski, S. Radulovic, D. Janic, L. Dokmanovic, P. Rodic, Z. Krstic

PP 67 CHARACTERISTICS AND MANAGEMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOODK. Martinova, O. Muratovska, S. Glamocanin, Z. Antevska-Trajkova, B. Conevska, S. Koceva

PP 68 SAFETY OF LUMBAR PUNCTURE IN THROMBOCYTOPENIA - PROPHYLACTIC PLATELET TRANSFUSIONS BEFORE LUMBAR PUNCTURE; YES OR NO L. Kitanovski, A. Trampus-Bakija, M. Benedik-Dolnicar

PRINCIPLES OF HAEMOPHILIA CARE

PP 78 IS THERE AN IMPROVEMENT IN THE HEMOPHILIA CARE IN MACEDONIA?S. Stankovic, T. Smilevska, T. Sotirovska, S. Trajkova, A. Ljatifi

PP 79 SOME CHARACTERISTICS OF PATIENTS WITH HEMOPHILIA IN REPUBLIC OF SRPSKA - BOSNIA AND HERZEGOVINAJ. Predojevic-Samardzic, B. Djurdjevic-Banjac, D. Malcic-Zanic

PP 80 MULTICENTRIC EVALUATION OF HEALTH-RELATED QUALITY OF LIFE IN ROMANIAN HAEMOPHILIACS M. Serban, M.D.Mihailov, L. Pop, A. Lacatusu, L. Rittli, P. Stancu, A. Cucuianu, E. Ursu

PP 81 GENETIC DIAGNOSIS OF HAEMOPHILIA AND PRENATAL DIAGNOSIS. SLOVENIAN EXPIERENCESM. Benedik-Dolnicar, L. Kitanovski, M. Debeljak

PP 82 HEMOREC - A CLINICAL REGISTRY FOR HAEMOPHILIA PATIENTSP. Brabec, T. Pavlík, P. Salaj

PP 83 SUCCESFULL TREATMENT OF HUGE ILIOPSOAS HEMATHOMA IN PATIENT WITH MILD HEMOPHILIA AM. Vucic, T. Vukicevic, N. Govedarovic, L. Macukanovic-Golubovic

PP 84 ILIOPSOAS BLEEDING IN CHILDHOOD HAEMOPHILIA - SINGLE CENTER EXPERIENCEP. Rodic, L. Dokmanovic, N. Krstovski, J. Lazic, Z. Smoljanic, D. Janic



PP 85 ORTHOPEDIC STATUS OF HEMOPHILIACS IN ROMANIA – A MULTICENTRIC STUDYL. Pop, L. Rittli, P. Stancu, A. Cucuianu, D. Mihailov, A. Lacatusu, E. Ursu, L. Barna, W. Schramm, M. Serban

PP 86 HIP SURGERY IN A HEMOPHILIC PATIENTS. Stankovic, A. Stojanovic, T. Smilevska, Z. Stojanovski, T. Sotirova, S. Trajkova, M. Lozance, A. Latifi , D. Dukovski, L. Cevreska

PP 87 INHIBITORS IN HEMOPHILIA PATIENTS IN UKRAINEO. Stasyshyn, V. Krasivska, V. Novak

PP 88 SUCCESSFUL TREATMENT OF INTRACRANIAL HAEMORRHAGE AND COMPARTMENT SYNDROME OF THE NECK IN PATIENT WITH HAEMOPHILIA A AND INHIBITORSD. Antic, I. Elezovic, P. Miljic, L. Davidovic, P. Djoric

PP 89 RECOMBINANT FACTOR VIIa IN TREATMENT OF NONTRAUMATIC SPONTANEOUS INTRAMURAL SMALL-BOWEL HAEMATHOMA IN HAEMOPHILIA A PATIENT - CASE REPORTI. Savic, I. Percic, N. Rajic, S. Popovic, B. Pilipovic

PP 90 RECOMBINANT FACTOR VIIa FOR TREATMENT OF ACQUIRED HAEMOPHILIA - CASE REPORT D. Markovic, T. Vukicevic, E. Miljkovic, M. Pavlovic

PP 91 THE EFFECTIVENESS OF DDAVP IN PREVENTING OF BLEEDING IN PATIENTS WITH VON WILLEBRAND DISEASE UNDERWENT ORAL SURGERY PROCEDURESM. Gardasevic, S. Colic, M. Jurisic, V. Jurisic

ARTERIAL THROMBOSIS: RISK FACTORS AND THERAPY

PP 104 RELATIONSHIP OF ALCOHOL CONSUMPTION AND THROMBOGENIC FACTORS IN HYPERTENSIVE MALESG. Vyssoulis, E. Karpanou, V. Tzamou, G. Theodosiadis, D. Adamopoulos, G. Antonakoudis, D. Cokkinos, C. Stefanadis

PP 105 FIBRINOGEN OF LOW MOLECULAR WEIGHT AND ITS ROLE IN ATHEROGENESIS AT PATIENTS WITH DIABETES MELLITUS 2nd TYPEA. Doronina, V. Lipinski, I.N. Bokarev

PP 106 THE COMPLEX’S ACTIVITY “VON WILLEBRAND FACTOR – GLYCO-PROTEIN IIb/IIIa” AT THE PATIENTS WITH ATHEROTHROMBOSIS OF THE HEART (CORONARY ARTERY DISEASE) AND PERIPHERAL ARTERIES (PERIPHERAL ARTERY DISEASE) PROGRESSING ON BACKGROUND OF DIABETES MELLITUS TYPE 2I. Smirnova



PP 107 ANTIOXIDATIVE PROPERTIES OF MOMORDICA CHARANTIA ON OXIDATION OF NATIVE AND MODIFIED LDLG. Sobal, W. Lehner, G. Stubiger, H. Sinzinger

PP 108 ANTI BETA 2 GLYCOPROTEIN I ANTIBODIES AT PATIENTS WITH DVT, CVI AND AMIV. Neceva, S. Kostovska, R. Apostolovska

PP 109 ELEVATIONS IN SOLUBLE CD40 LIGAND IN PATIENTS WITH HIGH PLATELET AGGREGABILITY UNDERGOING PCIS. Obradovic, J. Antovic, N. Antonijevic, V. Subota, D. Vojvodic, B. Gligic, J. Marinkovic, D. Obradovic, H. Wallen

PP 110 INTRAVENOUS TISSUE-TYPE PLASMINOGEN ACTIVATOR THERAPY FOR ISCHAEMIC STROKE: NIS STROKE TEAM EXPERIENCE N. Vukasinovic, S. Jolic, M. Zivkovic, M. Cvejic

FREE PAPERS

PP 111 DISSEMINATED INTRAVASCULAR COAGULATION AT AN EARLY PHASE OF TRAUMAA. Sawamura, S. Gando, M. Hayakawa, H. Hoshino, N. Kubota, N. Henzan, M. Sugano, T. Wada, K. Katabami

PP 112 HAEMOSTATIC DISORDERS IN PATIENTS WITH MASSIVE TRANSFUSIONT. Makarovska-Bojadzieva, S. Kostovska, E. Todorovska, M. Blagoevska,O. Damevska-Todorovska, E. Velkova, J. Angelovski, I. Nikoloska

PP 113 ANTIPHOSPHOLIPID SYNDROME AND HELICOBACTER PYLORY INFECTION - CASE REPORT O. Simonovic, L. Macukanovic-Golubovic, T. Vukicevic, D. Tasic

PP 114 THE MOST COMMON COAGULATION DISORDERS IN PATENTS WITH SOLID TUMORS - OUR EXPERIENCESLj. Tomasic, V. Vukov, A. Babic, B. Savic, V. Libek, A. Kulic, L. Mijovic, N. Rankovic

PP 115 USE OF PLATELETS IN PATIENTS WITH MALIGNANT DISEASESA. Antic, Z. Stanojkovic

PP 116 DEVELOPMENT OF THE DISEASE AND FATAL OUTCOME IN A PATIENT WITH BERNARD-SOULIER SYNDROMES. Stankovic, L. Cevreska, T. Smilevska, T. Sotirovska, S. Trajkova, L. Hadzi-Pecova, A. Ljatifi , D. Dukovski

PP 117 THE TREATMENT OF CRITICAL BLEEDING EPISODES IN PATIENTS WITH SERIOUS HAEMATOLOGICAL DISORDERS WITH RECOMBINANT FACTOR VIIa N. Rajic, A. Savic, .S. Popovic, I. Savic, I. Urosevic, D. Agic, B. Zeravica,N. Vlaisavljevic, I. Percic, D. Pejin



PP 118 DIFFUSE CAVERNOUS HEMANGIOMA OF THE LEFT LEG, VULVA ET UTERUS IN A PREGNANT WOMAN: REPORT OF A RARE CASEI. Djunic, I. Elezovic, O. Markovic, J. Tadic, D. Tomin, D. Antic, A. Vidovic, A. Ljubic

PP 119 BIOLOGICAL EVALUATION OF SYNTHETIC LINEAR ANALOGUE PEPTIDES OF 1811-1818 LOOP OF THE A3 SUBUNIT OF THE LIGHT CHAIN A3-C1-C2 OF FVIII BLOOD COAGULATIONK. Patsialas, C.H. Koutsas, P.E. Makris, M. Liakopoulou–Kyriakides

PP 120 THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR IN PATIENTS WITH DIABETES MELLITUS TYPE 2 J. Stasko, P. Chudy, P. Holly, P. Galajda, I. Plamenova, P. Kubisz

PP 121 RADIONUCLIDE THERAPY WITH 153-SAMARIUM-EDTMP TEMPORARILY DECREASES PLATELET COUNT PARALLELEDBY AN INCREASED CELLULAR THROMBOXANE FORMATION E. Trifi na, A. Oguogho, J. Hiltunen, H. Sinzinger

PP 122 PLATELET LABELLING EFFICIENCY IS INFLUENCED NOT ONLY BY QUANTITATIVE BUT ALSO QUALITATIVE LIPOPROTEIN COMPOSITION F. Hajos, S. Granegger, B. Palumbo, R. Palumbo, H. Sinzinger

PP 123 IMPACT OF VALPROATS ON THE PLATELET NUMBER AND FUNCTIONZ. Igrutinovic, S. Obradovic, B. Vuletic, S. Markovic, A. Vujic, Z. Raskovic

PP 124 HAEMOVIGILANCE AND PHARMACOVIGILANCE IN MEDICATION OBTAINED FROM HUMAN PLASMAM. Romic

Gene

ral I

nfor

mat

ion


“I have found a most beautiful, ancient place, the great city of Belgrade, by chance destroyed and bereft of people, and I rebuilt it and dedicated it to Our Lady, the Most Holy Mother of God”, wrote Serbian ruler Despot Stefan Lazarevic, poet and humanist. He erected a beautiful city with a fortifi ed castle, and two river ports.

Belgrade is the administrative and cultural capital of Serbia.

The city is situated where the Sava River fl ows into the mighty Danube, and where the cultivated Panonian Plain meets the hilly and mountainous Balkans.

Though a metropolis scared with history, it remains unquenchably optimistic. Belgrade is a hospitable and lively city. It is a wild, untamable city, to be loved rather than merely appreciated.

The best time for a visit is in spring. In May and June, the sweet smell of linden trees pervades many of its streets. A short walk to one of the riverbanks provides an escape from the city bustle, and offers a choice of numerous restaurants built on rafts.

Because all of this and much more, Belgrade is a city to enjoy, and feel surprisingly good in.

Belgrade


Meeting Venue

BEST WESTERN Hotel M

Bulevar oslobođenja 56a11000 Belgrade, SerbiaTel: + 381 11 30 90 505 Website: www.hotel-m.com

Meeting DateMay 14 – 16, 2009

LanguageThe offi cial language of the Meeting is English.

WebsiteThe offi cial website of the Meeting is www.DanubianLeagueBelgrade.com

BadgesAll participants will receive name badge at the registration desk. Badge should be visible all times at the Meeting venue.

Badges have been coded as folows:Orange ParticipantsBlue ExhibitorsYellow Organizators

ExhibitionA commercial exhibition of pharmaceutical items and technical equipment will be organized during the Meeting.

The exhibition is opened:

Thursday May 14 14:00 – 19:00Friday May 15 09:00 – 17:00Saturday May 16 09:00 – 15:00

On-site SecretariatThe Registration and Information Desk willoperate at the Meeting venue:

Thursday May 14 12:00 – 19:00Friday May 15 08:30 – 19:00Saturday May 16 08:30 – 15:30

Registration Fee on-site150 EUR (in RSD)

The on-site registration fee for participants covers:- Access to the Scientifi c Sessions and

Exhibition- Printed material of the Meeting- Certifi cate of Attendance- Opening Ceremony & Welcome Reception,

May 14, 2009- Lunch and Coffee Break, May 14 – 16, 2009

Technical Organizer & Offi cial Travel AgencyTP “Mladost turist” A.D.

Bulevar Oslobođenja 56a , 11000 Belgrade, SerbiaTel: + 381 11 3095 505, Fax: + 381 11 3095 506

E-mail: [email protected] Website: www.hotel-m.com

General Information


Scientifi c Information

Oral Sessions Oral sessions include:Plenary Lectures – 30 minState of the Art – 20 minOral Presentations – 10 min

Slide preview room is available.

Please hand your presentation at least 2 hours before start of your session.

Poster SessionPosters should be mounted at the designated area in Room Forum according to the numbers given in the fi nal Programme.

Helmut Vinazzer AwardThe author of the best poster will be awarded at the Gala Dinner, May 15.

Abstract Book and Programme The Abstract Book and Programme will be included in the Meeting bags.

Certifi cate of AttendanceA Certifi cate of Attendance will be given to each registrated participant during the Meeting.

Social Events

Opening Ceremony Thursday, May 14, 200919:00-19:45Room Atrium

Welcome ReceptionThursday May 14, 200920:00 – 22:00Business Centre

Included in the registration fee.

Gala DinnerFriday, May 15, 200920:30-00:00Kalemegdanska terasa

Included in the registration fee for the fi rst 250 participants.

Visit to the Royal PalaceSunday, May 16, 200908:30-10.00

Visit organized forone hundred participants.

Spon

sorin

g an

d Ex

hibi

tion


THURSDAY, MAY 14 17:00-18:00 Bayer Health Care, Bayer Schering Pharma Recombinant FVIII and hemophilia A

Maria Elisa MancusoUsage of rFVIII in children in Italy

Nada Gvozdenovic-RasovicFirst experience with rFVIII in the treatment of patient with severe hemophilia A

Dusan AvramovicXarelto - the fi rst oral, direct Factor Xa inhibitor

18:00-19:00 Siemens Healthcare Diagnostics and Interlab exim

Christine Dahler- Challenges and benefi ts of D-dimer testing- The new INNOVANCE D-Dimer - State-of-the-art antithrombin testing

Richard Morales- The Next Generation of Hemostasis Analyzers, the CS-2000i

FRIDAY, MAY 1513:00-14:00 Novo Nordisk

Guenter Auerswald Prophylaxis in patients with inhibitors to haemophilia A

Ivo Elezovic Acquired haemophilia-are we aware enough?

17:15-17:30 Instrumentation Laboratory

Alberto StradaInnovation is here – IL proposal to modern coagulation lab

17:30-18:30 Baxter

SATURDAY, MAY 1613:00-14:00 Octapharma Human proteins for human patients

Erling NorrbyThe evolutionary chess game between viruses and man - Subcellular infection agents: viruses, prions and more

Andrea Neisser-SvaePathogen inactivaton - The defi nitive safeguard for plasma

Satellite Symposia

PROGRAMME - uhts.org.rs · Professor Aleksandar Lucic President DLTH Meeting 2009 Welcome Message....

Documents

Transcript of PROGRAMME - uhts.org.rs · Professor Aleksandar Lucic President DLTH Meeting 2009 Welcome Message....